FindTrial
Sign In

Comparing Ropivacaine and Levobupivacaine for Ultrasound-Guided Axillary Plexus Block.

Randomized control study of Ropivacaine 0r Levobupivacaine in Ultrasound-guided axillary plexus block in adult patients undergoing upper limb surgeries.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060527
Enrollment
80
Registered
2023-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M84- Disorder of continuity of bone Health Condition 2: M662- Spontaneous rupture of extensor tendons

Interventions

Intervention1: Ultrsound guided axillary plexus block: Randomised control study of Ropivacaine and Levobupivacaine in Axillary plexus block in adults patient.Each drug will be taken 25 ml . Drug will

Sponsors

LLRM medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and grade II Patients Age- 18 to 65 years of either sex Patients undergoing elective upper limb surgeries

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA Patient refusal Infection at the injection site, Coagulopathy, Pregnancy, Any severe systemic disease

Design outcomes

Primary

MeasureTime frame
The onset of sensory block The onset of motor block Duration of motor blockadeTimepoint: The block effect will be checked at1,2,3,4,5,10,15,30,60,90,120,150 mins . Till the 24 hour .—

Secondary

MeasureTime frame
Duration of postoperative analgesia Hemodynamic changes Any complicationsTimepoint: Nil—

Countries

India

Contacts

Public ContactTilak singh

LLRM MEDICAL COLLEGE MEERUT

Drvipindhama@yahoo.com9760014177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026